We Are the Frontier

Gene HOXA10 Protects Bone Stem Cell Supply in Mice

The finding points to HOX genes as possible targets for bone repair, though the work remains at the animal and cell-culture stage.

Updated on Nov. 6, 2026 in Science

Bold vector editorial illustration of a teal bone cross-section with glowing amber cells clustered in the marrow, set against a cream background.
Researchers at NYU Langone found that the gene HOXA10 protects bone stem cell supplies in mice, and that its loss impairs bone repair. AI Illustration. Upload story photo >

Researchers at NYU Langone Health identified the gene HOXA10 as a lifelong protector of bone stem cell supplies in mice, according to a study published online November 4 in Science Advances. Mice engineered to lack HOXA10 action could not heal properly after breaking a bone; the work is at the animal-study stage.

Why it matters

The finding places HOX genes at the center of how bone maintains its regenerative reserve over a lifetime, a line of work that could inform future approaches to bone repair. Because the evidence comes from mice and cultured human cells, it points toward a therapeutic target rather than a treatment.

The study compared engineered mice against controls, finding stem cell progenitors in the healing callus at 48 percent versus 76 percent. In cultured human bone cells, silencing three related HOX genes raised apoptosis, or programmed cell death, by 50 percent, a larger effect than seen in mouse cells, though whether that holds in living human bone remains untested.

The players

NYU Langone Health

A New York academic medical center whose researchers led the study on HOX genes and bone stem cell maintenance.

Dr. Leucht

A researcher whose 2023 study showed that boosting HOXA10 activity could improve fracture healing in older mice.

The details

HOX genes are a family of genes that help direct how tissues develop and organize. The team tagged HOXA10-expressing stem cells with a fluorescent green marker so they could trace them, and built in a way to switch the HOXA10 genes off on command. When HOXA10 was deleted in six-day-old mouse pups, the stem cell supply declined steadily over the following months. The loss also disrupted collagen, the structural protein that lays the early framework for rebuilding bone, leaving the repair process disorderly.

Timeline

  1. 2023: a prior study showed that increasing HOXA10 activity improved fracture healing in older mice.

  2. November 4, 2026: the new study was published online in Science Advances.

  3. Mice were tracked for 15 months after HOXA10 deletion.

The Tech Race

The work builds on Dr. Leucht's 2023 demonstration that raising HOXA10 activity improved fracture healing in older mice. The new results shift the question toward how the regenerative reserve is maintained across a lifetime, and whether HOX genes can be engineered to sustain it.

The results are from mice and cultured human cells, so no treatment is available and no timeline for clinical use has been announced. Readers with an interest in bone healing should understand that HOX-targeted approaches remain at the research stage.

The takeaway

The key trajectory is that maintaining bone's regenerative reserve across a lifetime may depend on HOX genes, which could make them a target for future bone repair work. Watch for follow-up studies testing whether HOXA10-linked approaches hold up in larger animal models or living human bone.

Further reading

For broader context on the research behind this result, explore more Life Sciences coverage.

Source note: This article includes information reported by Technology Networks.